David Ridley PhD

David Ridley is the Faculty Director for Health Sector Management at Duke University’s Fuqua School of Business. He studies pharmaceutical innovation, manufacturing, and prices. He is especially interested in how to encourage development of drugs and vaccines for neglected diseases. David was the lead author of the paper proposing the priority review voucher program which became law and created a market of more than a billion dollars for drug development for neglected diseases. His research has been funded by the Bill & Melinda Gates Foundation and the National Institutes of Health. David teaches courses on health care policy and strategy to Duke University graduate students. He received a doctorate in economics from Duke University.

Edmonson C, Hayes R, Horton P, Peterson D, Strawn J, Taylor DH. Strategies to expand the distribution of nursing talent in the United States. Nursing outlook. 2024 Jan;72(1):102003.

Kaufman BG, Jones KA, Greiner MA, Giri A, Stewart L, He A, et al. Health Care Use and Spending Among Need-Based Subgroups of Medicare Beneficiaries With Full Medicaid Benefits. JAMA health forum. 2023 May;4(5):e230973.

Johannesson JM, Glover WA, Petti CA, Veldman TH, Tsalik EL, Taylor DH, et al. Access to COVID-19 testing by individuals with housing insecurity during the early days of the COVID-19 pandemic in the United States: a scoping review. Front Public Health. 2023;11:1237066.